Supplementary Material 3

Figshare2025-03-03 更新80

Additional file 3 of Exosome-transmitted LUCAT1 promotes stemness transformation and chemoresistance in bladder cancer by binding to IGF2BP2

膀胱癌耐药性

外泌体分子机制

Supplementary Material 3

DataCite Commons2025-03-03 更新50

High glucose associated YTHDC1 lactaylation reduces the sensitivity of bladder cancer to enfortumab vedotin therapy. High glucose associated YTHDC1 lactaylation reduces the sensitivity of bladder cancer to enfortumab vedotin therapy

膀胱癌耐药性

糖代谢与肿瘤治疗

Hyperglycemia has been reported to be a risk factor for bladder cancer (BC). Enfortumab vedotin (EV), the first antibody-drug conjugates targeting NECTIN4, has shown promising clinical efficacy in pat

NIAID Data Ecosystem00

Additional file 3 of Exosome-transmitted LUCAT1 promotes stemness transformation and chemoresistance in bladder cancer by binding to IGF2BP2

资源简介：

相关数据集